PEDI Pediatric Autoimmune Neuropsychiatric Disorder Associated With Streptococcus Study

Part of paid clinical trials in Lebanon, New Hampshire.

Sponsor
University of Wisconsin, Madison
Study ID
NCT06811935
Status
Recruiting
Apply to this trial

Conditions

  • PANDAS
  • PANS

Eligibility Criteria

Sex
ALL
Age
3 Years - 17 Years
Healthy Volunteers
Not accepted

Study Details

The objective of the Pediatric Epidemiological Data and Incidence (PEDI) PANDAS study is to demonstrate the feasibility of enrollment and retention of subjects in a study to determine the incidence and natural history of children with Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS) with regard to spectrum, course and outcome. The investigators aim to demonstrate they can recruit and retain 85% of children who are eligible for this study. Eligible children are those who fit criteria for PANS and Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcus (PANDAS). Each child will be followed for one year.

Key Dates

Start date
Feb 17, 2025
Status verified
Jan 2026
Primary completion
Dec 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
30 participants (estimated)

Arms

  • Arm: Children with PANS or PANDAS
    This cohort will include participants from an In Primary Care Group where the patient is a current member of the primary care population at either UW Health or Dartmouth Health and an External to Primary Care Group.

Primary Outcome Measure

Percentage of Eligible Participants Enrolled [ Time Frame: up to 12 months ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Dartmouth Hitchcock Medical CenterLebanonNew Hampshire03766
Juliette Madan, MD, MS (PRINCIPAL_INVESTIGATOR)
UW School of Medicine and Public HealthMadisonWisconsin53792
Ellen R Wald, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Lebanon, NH

By research site
Dartmouth Hitchcock Medical Center· Lebanon, NHUW School of Medicine and Public Health· Madison, WI

Related Studies